Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Antiepileptic Drugs May Not Independently Impair Cognition

Publish date:: February 13, 2020

Key clinical point: Antiepileptic drug therapy is not associated with impairments in objective or subjective cognitive function above other clinically relevant factors.

Major finding: Increasing seizure frequency was associated with objective cognitive dysfunction, and depression was associated with subjective cognitive impairment.

Study details: A cross-sectional analysis of 331 prospectively enrolled patients who were admitted to a video EEG monitoring unit.

Disclosures: The study was conducted without external funding. Dr. Foster and other investigators reported research funding from professional associations and pharmaceutical companies that was unrelated to the study.

Citation:

Foster E et al. Neurology. 2020 Feb 3. doi: 10.1212/WNL.0000000000009061.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Epilepsy & Seizures

Study supports halting antiseizure medications after neonatal seizures,

CBD for LGS: Fewer seizures, but thrombocytopenia risk,

Preventive treatment delays first seizure onset in tuberous sclerosis complex,

Listening to Mozart helps tame epilepsy,

In epilepsy, brain-responsive stimulation passes long-term tests,